Advertisement
Person › Details
Gregory Winter (MRC (GB), Laboratory of Molecular Biology (MRC-LMB, Cambridge))
Winter, Gregory (MRC + CAT + Domantis + Nobel Laureate)
Organisation | MRC (GB), Laboratory of Molecular Biology (MRC-LMB, Cambridge) | |
Group | United Kingdom (GB) (govt) | |
Former/major organisation | Cambridge Antibody Technology (CAT) (Group) | |
Group | AstraZeneca (Group) | |
Product | therapeutic antibody | |
Record changed: 2023-02-23 |
Advertisement
More documents for Gregory Winter
- [1] Maxion Therapeutics Ltd.. (2/15/23). "Press Release: Maxion Therapeutics’ $16 Million Series A to Drive Antibody Development for Previously Untreatable Ion Channel and GPCR-driven Diseases". Cambridge....
- [2] Bit Bio Ltd.. (10/25/21). "Press Release: bit.bio Expands Board of Directors with Appointment of Entrepreneurs and Nobel Laureate". Cambridge....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top